James Loerop - 08 Jul 2021 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP Business Development
Signature: /s/ James Loerop
Issuer symbol: ANIK
Transactions as of: 08 Jul 2021
Net transactions value: -$31,608
Form type: 4
Filing time: 12 Jul 2021, 16:15:29 UTC
Next filing: 01 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+3,000	+90%	$0.000000	6,323	08 Jul 2021	Direct	F1
transaction	ANIK	Common Stock	Tax liability	$31,608	-731	-12%	$43.24	5,592	08 Jul 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	+3,000		$0.000000	3,000	08 Jul 2021	Common Stock	3,000	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of RSUs granted on July 8, 2019.
F2	Reflects an aggregate of 731 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on July 8, 2021.
F3	Reflects the closing price of ANIK common stock on July 8, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.